TrialAnnals of medicine2022

The prospective multiple-centre randomized controlled clinical study of high-dose amoxicillin-proton pump inhibitor dual therapy for

Cheng Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.